COMMUNIQUÉS West-GlobeNewswire

Rafael Pharmaceuticals Announces Activation of Second Clinical Trial Site for the Phase I Study of CPI-613 in Patients with Relapsed or Refractory T-Cell Lymphoma

13/08/2018 - 17:15

Interim results of CPI-613 in combination with bendamustine in patients with T-Cell Lymphoma exhibited an 86% Objective Response Rate Newark, NJ, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader [...]

Major shareholding announcement

13/08/2018 - 17:13

Company Announcement 13 August 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]

Nordic Transport Group Holding A/S announces final result of takeover offer

13/08/2018 - 16:31

Company Announcement 13 August 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]

Nextech and Solutionreach announce partnership to improve provider and patient communications

13/08/2018 - 16:08

Product integration delivers new patient relationship management solutions to specialty providers TAMPA, Fla., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of healthcare technology solutions [...]

Golden Leaf To Acquire Tahoe – A Leading Nevada Producer

13/08/2018 - 16:03

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES PORTLAND, Ore., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“ Golden Leaf ” or the “ [...]

Invitation to investor meeting on August 16, 2018

13/08/2018 - 15:59

In connection with the release of BioPorto’s interim report covering the first six months of 2018, BioPorto will hold an investor meeting on August 16, 2018 at. 3 pm. at BioPorto’s address Tuborg Havnevej 15, st., 2900 [...]

Quad Video Halo Inc, a subsidiary of Spine Injury Solutions Inc. announces signing of a new subscription agreement with multi-office healthcare provider

13/08/2018 - 15:00

HOUSTON, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN) announced today its subsidiary, Quad Video HALO Inc. (QVH), has reached an agreement with an injury relief treatment center for a [...]

Veritas Signs MOU with the Chamber of Commerce, Industry, Services and Tourism Brazil & Puerto Rico

13/08/2018 - 15:00

VANCOUVER, British Columbia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company) is pleased to announce that it has entered into a Memorandum [...]

Protech Home Medical Announces Date and Time for Quarterly Conference Call

13/08/2018 - 15:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Protech Home [...]

Advantis Corp. Set to Report 20% Revenue Increase as New Products Launch

13/08/2018 - 15:00

NEWPORT BEACH, CA , Aug. 13, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) is set to report that revenue has increased over twenty percent over the first quarter and expects the current rate of growth [...]

CFN Exclusive Interview: Lexarias DehydraTECH Could Transform the $680 Billion Tobacco Industry -- CFN Media

13/08/2018 - 14:45

SEATTLE, WA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of a CEO video [...]

Marrone Bio Innovations Submits Novel Bioherbicide to the EPA for Regulatory Approval

13/08/2018 - 14:31

DAVIS, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and [...]

Diffusion Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update

13/08/2018 - 14:30

Enrollment continues in Phase 3 GBM brain cancer trial Key European patent validated covering oral formulation of TSC Preparing for Phase 2 stroke trial with in-ambulance administration of TSC CHARLOTTESVILLE, Va., Aug [...]

Eyenovia’s EYN PG21 Trial Evaluating High-Precision Microdose of Latanoprost Demonstrates Robust Intraocular Pressure Lowering and Patient Usability

13/08/2018 - 14:30

Positive results validate Eyenovia’s piezo-print technology for topical eye treatment as Company prepares for Phase III trials in progressive myopia, CACG and mydriasis NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- [...]

VistaGen Therapeutics and Baylor College of Medicine Collaborate on First-Step Study to Test VistaGen’s AV-101 for Potential Anti-Suicidal Effects in Veterans

13/08/2018 - 14:30

Veterans from Operation Enduring Freedom, Operation Iraqi Freedom and Operation New Dawn to Participate in Study SOUTH SAN FRANCISCO, Calif. and HOUSTON, Aug. 13, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. ( [...]

Pure Global Cannabis, Inc. Uniquely Positioned to Lead Cannabis Health & Wellness Market-- CFN Media

13/08/2018 - 14:30

SEATTLE, WA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article [...]

Hemispherx Updates Stockholders, Highlighting Ampligen’s Role in Enhancing Immunotherapeutic Therapies

13/08/2018 - 14:30

OCALA, Fla., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, is pleased to [...]

AIT Therapeutics Announces $20 Million Common Stock Purchase Agreement with Institutional Investor, Lincoln Park Capital Fund

13/08/2018 - 14:30

GARDEN CITY, N.Y., and REHOVOT, Israel, Aug. 13, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB) (“AIT Therapeutics or the “Company”), a clinical-stage medical device and biopharmaceutical company focused on [...]

Arbutus’ LNP Licensee Alnylam Announces FDA Approval of ONPATTRO™ (patisiran), for the Treatment of ATTR Amyloidosis

13/08/2018 - 14:30

ONPATTRO Approval Triggers Royalty to Arbutus Clinically Validated LNP Technology Now in the Hands of Genevant to Develop RNA-based Products WARMINSTER, Pa., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma [...]